Artiva Biotherapeutics, Inc. (ARTV) stock
ARTVNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
$3.86−0.10 (-2.53%)
Close on Nov 17, 2026Market cap $188.72MP/E –Yield –
Artiva Biotherapeutics price to book ratio
The price-to-book ratio is market cap divided by shareholders' equity.
Artiva Biotherapeutics's price to book ratio was 0.3× on Nov 11, 2026, against 0.3× a year earlier.
Price to Book Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2026 | Nov 11, 2026 | 0.3× | +0.2 |
| 2025 | Jan 31, 2025 | 0.1× | −0.1 |
| 2024 | Dec 31, 2024 | 0.3× | – |
See a number that looks wrong?